Loss of β-Ketoacyl Acyl Carrier Protein Synthase III Activity Restores Multidrug-Resistant Escherichia coli Sensitivity to Previously Ineffective Antibiotics.


Journal

mSphere
ISSN: 2379-5042
Titre abrégé: mSphere
Pays: United States
ID NLM: 101674533

Informations de publication

Date de publication:
29 06 2022
Historique:
pubmed: 17 5 2022
medline: 2 7 2022
entrez: 16 5 2022
Statut: ppublish

Résumé

Antibiotic resistance is one of the most prominent threats to modern medicine. In the latest World Health Organization list of bacterial pathogens that urgently require new antibiotics, 9 out of 12 are Gram-negative, with four being of "critical priority." One crucial barrier restricting antibiotic efficacy against Gram-negative bacteria is their unique cell envelope. While fatty acids are a shared constituent of all structural membrane lipids, their biosynthesis pathway in bacteria is distinct from eukaryotes, making it an attractive target for new antibiotic development that remains less explored. Here, we interrogated the redundant components of the bacterial type II

Identifiants

pubmed: 35574679
doi: 10.1128/msphere.00117-22
pmc: PMC9241538
doi:

Substances chimiques

Anti-Bacterial Agents 0
Fatty Acids 0
Membrane Lipids 0
Transferases (Other Substituted Phosphate Groups) EC 2.7.8.-
holo-(acyl-carrier-protein) synthase EC 2.7.8.7

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0011722

Références

J Biol Chem. 2003 Dec 19;278(51):51494-503
pubmed: 14523010
Proc Natl Acad Sci U S A. 2009 May 12;106(19):8009-14
pubmed: 19383799
Nat Microbiol. 2017 Mar 06;2:17028
pubmed: 28263303
J Biol Chem. 1996 Mar 22;271(12):6801-9
pubmed: 8636103
Antimicrob Agents Chemother. 1972 Apr;1(4):283-8
pubmed: 4208895
Genes (Basel). 2015 Oct 21;6(4):1113-24
pubmed: 26506392
J Biol Chem. 1980 Apr 25;255(8):3263-5
pubmed: 6988423
J Bacteriol. 1995 Aug;177(15):4224-9
pubmed: 7635809
J R Coll Physicians Edinb. 2016 Sep;46(3):150-156
pubmed: 27959347
J Bacteriol. 2019 Sep 6;201(19):
pubmed: 31331975
PLoS Pathog. 2015 Jun 01;11(6):e1004949
pubmed: 26030609
PLoS One. 2014 Aug 15;9(8):e104400
pubmed: 25126841
J Infect Dis. 2017 Feb 15;215(suppl_1):S28-S36
pubmed: 28375512
Mol Microbiol. 2019 Oct;112(4):1339-1349
pubmed: 31400173
J Bacteriol. 1985 Nov;164(2):861-5
pubmed: 3902801
mBio. 2021 Jun 29;12(3):e0092821
pubmed: 34134515
PLoS One. 2011;6(10):e26578
pubmed: 22053197
Infect Immun. 1990 May;58(5):1281-9
pubmed: 2182540
Front Cell Dev Biol. 2020 Jul 14;8:586
pubmed: 32766244
Sci Rep. 2017 Dec 15;7(1):17629
pubmed: 29247166
J Biol Chem. 2021 Dec;297(6):101434
pubmed: 34801557
J Biol Chem. 1975 Sep 10;250(17):7074-7
pubmed: 1099101
EcoSal Plus. 2008 Sep;3(1):
pubmed: 26443744
Lancet. 2022 Feb 12;399(10325):629-655
pubmed: 35065702
Antimicrob Agents Chemother. 2019 Apr 25;63(5):
pubmed: 30782996
Chem Biol. 2005 May;12(5):507-9
pubmed: 15911368
Science. 1994 Apr 15;264(5157):382-8
pubmed: 8153625
Antimicrob Agents Chemother. 2016 Jun 20;60(7):4420-1
pubmed: 27230792
J Clin Microbiol. 2022 Mar 16;60(3):e0027621
pubmed: 34346716
Environ Microbiol. 2021 May;23(5):2683-2691
pubmed: 33830615
Biochim Biophys Acta. 2009 May;1794(5):808-16
pubmed: 19100346
BMJ. 2019 Jun 18;365:l4282
pubmed: 31213428
Nat Commun. 2020 Mar 20;11(1):1496
pubmed: 32198415
Proc Natl Acad Sci U S A. 2012 Sep 18;109(38):E2561-8
pubmed: 22908292
EcoSal Plus. 2018 Aug;8(1):
pubmed: 30066669
Int J Antimicrob Agents. 2015 Feb;45(2):130-6
pubmed: 25465526
Antimicrob Agents Chemother. 2010 Jul;54(7):2867-77
pubmed: 20421396
J Biol Chem. 1995 Jun 30;270(26):15531-8
pubmed: 7797547
Gene. 1988 Aug 15;68(1):159-62
pubmed: 2851489
Curr Biol. 2017 Jun 19;27(12):1757-1767.e5
pubmed: 28602657
J Bacteriol. 2014 May;196(9):1713-22
pubmed: 24532778
Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6640-5
pubmed: 10829079
mBio. 2020 Sep 22;11(5):
pubmed: 32963002
Front Microbiol. 2020 May 14;11:824
pubmed: 32477293
Am J Infect Control. 2004 May;32(3):177-83
pubmed: 15153930
Microbiol Mol Biol Rev. 2003 Dec;67(4):593-656
pubmed: 14665678
Molecules. 2019 Jan 11;24(2):
pubmed: 30641878
Biochim Biophys Acta Mol Cell Biol Lipids. 2017 Nov;1862(11):1300-1309
pubmed: 27668701
Mol Microbiol. 2016 Sep;101(6):1069-87
pubmed: 27309594
Annu Rev Microbiol. 2011;65:1-18
pubmed: 21639787
Proc Natl Acad Sci U S A. 2014 Apr 15;111(15):5694-9
pubmed: 24706808
mBio. 2020 Dec 15;11(6):
pubmed: 33323515
Antimicrob Agents Chemother. 2016 Nov 21;60(12):7372-7381
pubmed: 27697764
Microbiology (Reading). 1996 Oct;142 ( Pt 10):2871-7
pubmed: 8885403
mBio. 2020 Mar 10;11(2):
pubmed: 32156814
Plasmid. 2006 Mar;55(2):152-7
pubmed: 16139359
mBio. 2017 Jan 3;8(1):
pubmed: 28049149
J Biol Chem. 2020 Jul 24;295(30):10340-10367
pubmed: 32499369
Mol Immunol. 2019 Apr;108:56-67
pubmed: 30784763
Microbiol Rev. 1993 Sep;57(3):522-42
pubmed: 8246839
Biotechnol Biofuels. 2014 Jan 09;7(1):7
pubmed: 24405789
J Infect Dis. 2018 Aug 14;218(6):979-990
pubmed: 29471349
Microbiol Mol Biol Rev. 2010 Jun;74(2):171-99
pubmed: 20508246
Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):17020-4
pubmed: 12471157

Auteurs

Yaoqin Hong (Y)

Centre of Immunology and Infection Control, School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, Queensland, Australia.

Jilong Qin (J)

Centre of Immunology and Infection Control, School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, Queensland, Australia.

Anthony D Verderosa (AD)

Centre of Immunology and Infection Control, School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, Queensland, Australia.

Sophia Hawas (S)

Centre of Immunology and Infection Control, School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, Queensland, Australia.

Bing Zhang (B)

Centre for Superbug Solutions, Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland, Australia.

Mark A T Blaskovich (MAT)

Centre for Superbug Solutions, Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland, Australia.

John E Cronan (JE)

Department of Microbiology, School of Molecular and Cellular Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.
Department of Biochemistry, School of Molecular and Cellular Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.

Makrina Totsika (M)

Centre of Immunology and Infection Control, School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, Queensland, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH